| Product Code: ETC12541807 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel continued to rely on imports of liposomal doxorubicin mainly from Switzerland, UK, Belgium, USA, and Germany. The low Herfindahl-Hirschman Index (HHI) indicates a market with diverse sources of supply. However, the negative Compound Annual Growth Rate (CAGR) from 2020 to 2024 suggests a declining trend in import volumes. The marginal decrease in growth rate from 2023 to 2024 highlights a relatively stable market environment for liposomal doxorubicin imports into Israel. Monitoring these trends can provide valuable insights for stakeholders in the pharmaceutical industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Liposomal Doxorubicin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Liposomal Doxorubicin Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Liposomal Doxorubicin Market - Industry Life Cycle |
3.4 Israel Liposomal Doxorubicin Market - Porter's Five Forces |
3.5 Israel Liposomal Doxorubicin Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 Israel Liposomal Doxorubicin Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Israel Liposomal Doxorubicin Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.8 Israel Liposomal Doxorubicin Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Israel Liposomal Doxorubicin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing adoption of liposomal doxorubicin for cancer treatment |
4.2.3 Technological advancements in drug delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with liposomal doxorubicin treatment |
4.3.3 Competition from alternative cancer treatment options |
5 Israel Liposomal Doxorubicin Market Trends |
6 Israel Liposomal Doxorubicin Market, By Types |
6.1 Israel Liposomal Doxorubicin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Liposomal Doxorubicin Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 Israel Liposomal Doxorubicin Market Revenues & Volume, By Doxil, 2022 - 2032F |
6.1.4 Israel Liposomal Doxorubicin Market Revenues & Volume, By Lipodox, 2022 - 2032F |
6.1.5 Israel Liposomal Doxorubicin Market Revenues & Volume, By Myocet, 2022 - 2032F |
6.1.6 Israel Liposomal Doxorubicin Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Israel Liposomal Doxorubicin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Liposomal Doxorubicin Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.2.3 Israel Liposomal Doxorubicin Market Revenues & Volume, By Ovarian Cancer, 2022 - 2032F |
6.2.4 Israel Liposomal Doxorubicin Market Revenues & Volume, By Multiple Myeloma, 2022 - 2032F |
6.2.5 Israel Liposomal Doxorubicin Market Revenues & Volume, By Kaposi's Sarcoma, 2022 - 2032F |
6.3 Israel Liposomal Doxorubicin Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Liposomal Doxorubicin Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 Israel Liposomal Doxorubicin Market Revenues & Volume, By Cancer Treatment Centers, 2022 - 2032F |
6.3.4 Israel Liposomal Doxorubicin Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.3.5 Israel Liposomal Doxorubicin Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4 Israel Liposomal Doxorubicin Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Liposomal Doxorubicin Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.4.3 Israel Liposomal Doxorubicin Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.4.4 Israel Liposomal Doxorubicin Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
7 Israel Liposomal Doxorubicin Market Import-Export Trade Statistics |
7.1 Israel Liposomal Doxorubicin Market Export to Major Countries |
7.2 Israel Liposomal Doxorubicin Market Imports from Major Countries |
8 Israel Liposomal Doxorubicin Market Key Performance Indicators |
8.1 Research and development investment in liposomal doxorubicin technology |
8.2 Number of clinical trials involving liposomal doxorubicin in Israel |
8.3 Patient satisfaction and outcomes with liposomal doxorubicin treatment |
8.4 Adoption rate of liposomal doxorubicin by healthcare providers in Israel |
8.5 Rate of adverse events reported with liposomal doxorubicin therapy |
9 Israel Liposomal Doxorubicin Market - Opportunity Assessment |
9.1 Israel Liposomal Doxorubicin Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 Israel Liposomal Doxorubicin Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Israel Liposomal Doxorubicin Market Opportunity Assessment, By End User, 2022 & 2032F |
9.4 Israel Liposomal Doxorubicin Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Israel Liposomal Doxorubicin Market - Competitive Landscape |
10.1 Israel Liposomal Doxorubicin Market Revenue Share, By Companies, 2025 |
10.2 Israel Liposomal Doxorubicin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here